Non-HFE hemochromatosis: Genetics, pathogenesis, and clinical management

被引：3
作者：
Nelson J.E. [1 ]
Kowdley K.V. [1 ]
机构：
[1] Department of Medicine, Division of Gastroenterology, University of Washington Medical Center, Seattle, WA 98195
来源：
Current Gastroenterology Reports | 2005年 / 7卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Iron Overload; Hemochromatosis; Hereditary Hemochromatosis; Hepcidin Expression; Iron Responsive Element;
D O I：
10.1007/s11894-005-0069-y
中图分类号：
学科分类号：
摘要：
Recent advances in our understanding of iron metabolism and the epidemiology of iron overload disorders have shown that hereditary forms of hemochromatosis can result from mutations in several iron metabolism genes other than HFE, including Hamp, HJV, TFR2, and SCL40A. These "non-HFE" forms of hemochromatosis are much rarer than HFE-related hemochromatosis but exhibit a similar phenotype, and with the exception of ferroportin disease, a similar pattern of inheritance and parenchymal iron accumulation. Therefore, these diseases can be thought of as variant forms of a primary hepatic iron overload syndrome; thus, a unified approach can be used for evaluation and diagnosis. Management generally consists of periodic phlebotomies until iron is depleted. © Current Science Inc. 2005.
引用
收藏
页码：71 / 80
页数：9
相关论文
共 73 条
[31]  
Jacolot S., Le Gac G., Scotet V., Et al., HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype, Blood, 103, pp. 2835-2840, (2004)
[32]  
Merryweather-Clarke A.T., Cadet E., Bomford A., Et al., Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis, Hum Mol Genet, 12, pp. 2241-2247, (2003)
[33]  
Le Gac G., Scotet V., Ka C., Et al., The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype, Hum Mol Genet, 13, pp. 1913-1918, (2004)
[34]  
Delatycki M.B., Allen K.J., Gow P., Et al., A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis, Clin Genet, 65, pp. 378-383, (2004)
[35]  
Roetto A., Papanikolaou G., Politou M., Et al., Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat Genet, 33, pp. 21-22, (2003)
[36]  
Matthes T., Aguilar-Martinez P., Pizzi-Bosman L., Et al., Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene, Blood, 104, pp. 2181-2183, (2004)
[37]  
Majore S., Binni F., Pennese A., Et al., HAMP gene mutation c.208T> C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis, Hum Mutat, 23, pp. 400-408, (2004)
[38]  
Roetto A., Daraio F., Porporato P., Et al., Screening hepcidin for mutations in juvenile hemochromatosis: Identification of a new mutation (C70R), Blood, 103, pp. 2407-2409, (2004)
[39]  
Filali M., Le Jeunne C., Durand E., Et al., Juvenile hemochromatosis HJV-related revealed by cardiogenic shock, Blood Cells Mol Dis, 33, pp. 120-124, (2004)
[40]  
Huang F.W., Rubio-Aliaga I., Kushner J.P., Et al., Identification of a novel mutation (C321X) in HJV, Blood, 104, pp. 2176-2177, (2004)
12345678